510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION EXECUTIVE SUMMARY A. 510(k) Number: k122397

First Page		Document Content
Date: 2012-10-09 13:29:38 Glycoproteins Immune system Immunologic tests Immunology Rubella Immunoglobulin M Immunoassay Rheumatoid factor Antibody Biology Medicine Pediatrics		510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION EXECUTIVE SUMMARY A. 510(k) Number: k122397 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 387,76 KB Share Document on Facebook

	Microsoft Word - ABSTRACT_Validation of a New Immunoassay for Quantification of Topiramate.doc DocID: 1vj8Z - View Document
	Rapid, automated immunoassay for atazanavir in plasma and cerebrospinal fluid (CSF) using the ARK ATV-TestTM Michael K. Helms, PhD, MBA ARK Diagnostics, Inc. 7th International Workshop on Clinical Pharmacology of HIV The DocID: 1viL6 - View Document
	MONITORING METHOTREXATE BY ARKTM IMMUNOASSAY K. C. Kasper, A. Orozco, J. Nguyen, K. Chung, B. Moon and J. Valdez ARK Diagnostics Inc., Sunnyvale, CA Introduction DocID: 1v6PF - View Document
	What We Bring To Your Project: OUR ABILITIES Activity, Immunoassay, and Chemical detection formats Low, Medium and High Throughput systems DocID: 1v2uu - View Document
	Therapeutic Drug Monitoring Immunoassay for Efavirenz Kenneth C. Kasper1, Joanne Valencia1, Ki Chung1, Byung Sook Moon1, Johnny Valdez1, Anura Jayewardene2, Patricia Lizak2, and Francesca T. Aweeka2 ARK Diagnostics, Inc. DocID: 1uWz5 - View Document